Skip to main content
Caplight Logo









Hygieia Biological Laboratories

Hygieia Biological Laboratories

Private
Woodland, CaliforniaHealthcare & Life Scienceshttps://hygieialabs.com/

Last Round

Series B

May 2, 2023

Total Funding Raised

$5.28M

Company Overview

Hygieia Biological Laboratories is a biotechnology company that researches, develops, and manufactures innovative veterinary and human vaccines and pharmaceuticals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

autogenous vaccinesveterinary biologicsanimal vaccinescustom vaccinesanimal healthbacterinsvaccine manufacturinglivestock healthherd healthvet pharmaveterinary medicinebiotech manufacturingsemen extendercustom biologicsagtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hygieia Biological Laboratories Comparables

Compare Hygieia Biological Laboratories with similar companies based on industry and business-model similarity.

Hygieia Biological Laboratories comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vacci-Vet Inc.
86%
Medgene Labs
85%
Cambridge Technologies
84%

Hygieia Biological Laboratories Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 2, 2023
GrantSep 3, 2020

Hygieia Biological Laboratories Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Monthly visitors grew 160% MoM to 1.3K.

Hygieia Biological Laboratories Filings

Explore SEC and related filing metadata, where available.

Hygieia Biological Laboratories filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hygieia Biological Laboratories's valuation, stock price, and market status.

Is Hygieia Biological Laboratories a public or private company?

Hygieia Biological Laboratories is a private company.

What is the current stock price of Hygieia Biological Laboratories?

Hygieia Biological Laboratories is a private company, so its shares have no public market price. Caplight tracks Hygieia Biological Laboratories's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Hygieia Biological Laboratories worth (valuation)?

Valuation information for Hygieia Biological Laboratories is not publicly available.

Can I buy Hygieia Biological Laboratories stock?

Hygieia Biological Laboratories shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Hygieia Biological Laboratories's last funding round?

Hygieia Biological Laboratories's most recent funding round was Series B on May 2, 2023.

Who are the main investors in Hygieia Biological Laboratories?

Key investors in Hygieia Biological Laboratories include Firstime.

Will Hygieia Biological Laboratories IPO soon?

No public IPO plans have been announced for Hygieia Biological Laboratories.

How can I track Hygieia Biological Laboratories secondary market activity?

Caplight tracks bids, offers, and trades in Hygieia Biological Laboratories's shares on secondary markets.

Firmographic Details

HeadquartersWoodland, California
Employee Range48
Year Founded1991
Last FundingMay 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?